Presentation of lipoteichoic acid potentiates its inflammatory activity

Immunobiology

Volumn 213, Issue 6, 2008, Pages 519-529

  Deininger, Susanne ^a   Traub, Stephanie ^a   Aichele, Diana ^a   Rupp, Tamara ^a   Baris, Teodora ^a   Möller, Heiko M ^a   Hartung, Thomas ^a,b   von Aulock, Sonja ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b JOINT RESEARCH CENTRE   (Italy)

Author keywords

Bacteria; Cytokines; Inflammation; Lipoteichoic acid; Potency

Indexed keywords

ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; BORON; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOTEICHOIC ACID; PEPTIDOGLYCAN; POLYSTYRENE; RHODAMINE; SILICONE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY LABELING; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; CONTROLLED STUDY; COVALENT BOND; CYTOKINE RELEASE; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFLAMMATION; MATERIAL COATING; NONHUMAN; PRIORITY JOURNAL; SURFACE PROPERTY;

ANTIGEN PRESENTATION; CYTOKINES; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; TEICHOIC ACIDS;

EID: 44349180834     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2008.01.001     Document Type: Article

References (29)

1. Aasjord P., and Grov A. Immunoperoxidase and electron microscopy studies of staphylococcal lipoteichoic acid. Acta Pathol. Microbiol. Scand. [B] 88 (1980) 47-52
2. Brightbill H.D., Plevy S.E., Modlin R.L., and Smale S.T. A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J. Immunol. 164 (2000) 1940-1951
3. Deininger S., Stadelmaier A., von Aulock S., Morath S., Schmidt R.R., and Hartung T. Definition of structural prerequisites for lipoteichoic acid-inducible cytokine induction by synthetic derivatives. J. Immunol. 170 (2003) 4134-4138
4. Draing C., Pfitzenmaier M., Zummo S., Mancuso G., Geyer A., Hartung T., and von Aulock S. Comparison of lipoteichoic acid from different serotypes of Streptococcus pneumoniae. J. Biol. Chem. 281 (2006) 33849-33859
5. Gao J.J., Xue Q., Zuvanich E.G., Haghi K.R., and Morrison D.C. Commercial preparations of lipoteichoic acid contain endotoxin that contributes to activation of mouse macrophages in vitro. Infect. Immun. 69 (2001) 751-757
6. Han S.H., Kim J.H., Seo H.S., Martin M.H., Chung G.H., Michalek S.M., and Nahm M.H. Lipoteichoic acid-induced nitric oxide production depends on the activation of platelet-activating factor receptor and Jak2. J. Immunol. 176 (2006) 573-579
7. Hermann C., Spreitzer I., Schroder N.W., Morath S., Lehner M.D., Fischer W., Schutt C., Schumann R.R., and Hartung T. Cytokine induction by purified lipoteichoic acids from various bacterial species - role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release. Eur. J. Immunol. 32 (2002) 541-551
8. Hoebe K., Georgel P., Rutschmann S., Du X., Mudd S., Crozat K., Sovath S., Shamel L., Hartung T., Zahringer U., and Beutler B. CD36 is a sensor of diacylglycerides. Nature 433 (2005) 523-527
9. Kusunoki T., Hailman E., Juan T.S., Lichenstein H.S., and Wright S.D. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J. Exp. Med. 182 (1995) 1673-1682
10. Leeson M.C., and Morrison D.C. Induction of proinflammatory responses in human monocytes by particulate and soluble forms of lipopolysaccharide. Shock 2 (1994) 235-245
11. Lehner M.D., Morath S., Michelsen K.S., Schumann R.R., and Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J. Immunol. 166 (2001) 5161-5167
12. Levels J.H., Abraham P.R., van Barreveld E.P., Meijers J.C., and van Deventer S.J. Distribution and kinetics of lipoprotein-bound lipoteichoic acid. Infect. Immun. 71 (2003) 3280-3284
13. Lotz S., Aga E., Wilde I., van Zandbergen G., Hartung T., Solbach W., and Laskay T. Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2. J. Leukoc. Biol. 75 (2004) 467-477
14. Lynch N.J., Roscher S., Hartung T., Morath S., Matsushita M., Maennel D.N., Kuraya M., Fujita T., and Schwaeble W.J. L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of gram-positive bacteria, and activates the lectin pathway of complement. J. Immunol. 172 (2004) 1198-1202
15. Mancuso G., Tomasello F., Ofek I., and Teti G. Anti-lipoteichoic acid antibodies enhance release of cytokines by monocytes sensitized with lipoteichoic acid. Infect. Immun. 62 (1994) 1470-1473
16. Mattsson E., Hartung T., Morath S., and Egesten A. Highly purified lipoteichoic acid from Staphylococcus aureus induces procoagulant activity and tissue factor expression in human monocytes but is a weak inducer in whole blood: comparison with peptidoglycan. Infect. Immun. 72 (2004) 4322-4326
17. Mazzotti F., Beuttler J., Zeller R., Fink U., Wendel A., Hartung T., and Von Aulock S. In vitro pyrogen test - a new test method for solid medical devices. J. Biomed. Mater. Res. Part A 80 (2007) 276-282
18. Morath S., Geyer A., and Hartung T. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193 (2001) 393-397
19. Morath S., Geyer A., Spreitzer I., Hermann C., and Hartung T. Structural decomposition and heterogeneity of commercial lipoteichoic acid preparations. Infect. Immun. 70 (2002) 938-944
20. Morath S., Stadelmaier A., Geyer A., Schmidt R.R., and Hartung T. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J. Exp. Med. 195 (2002) 1635-1640
21. Opal S.M., and Gluck T. Endotoxin as a drug target. Crit. Care Med. 31 (2003) S57-S64
22. Pfeiffer A., Bottcher A., Orso E., Kapinsky M., Nagy P., Bodnar A., Spreitzer I., Liebisch G., Drobnik W., Gempel K., Horn M., Holmer S., Hartung T., Multhoff G., Schutz G., Schindler H., Ulmer A.J., Heine H., Stelter F., Schutt C., Rothe G., Szollosi J., Damjanovich S., and Schmitz G. Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur. J. Immunol. 31 (2001) 3153-3164
23. Schröder N.W., Morath S., Alexander C., Hamann L., Hartung T., Zahringer U., Gobel U.B., Weber J.R., and Schumann R.R. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278 (2003) 15587-15594
24. Stadelmaier A., Figueroa-Perez I., Deininger S., Von Aulock S., Hartung T., and Schmidt R.R. A Staphylococcus aureus lipoteichoic acid (LTA) derived structural variant with two diacylglycerol residues. Bioorg. Med. Chem. 14 (2006) 6239-6254
25. Tone M., Powell M.J., Tone Y., Thompson S.A., and Waldmann H. IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3. J. Immunol. 165 (2000) 286-291
26. Travassos L.H., Girardin S.E., Philpott D.J., Blanot D., Nahori M.A., Werts C., and Boneca I.G. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 5 (2004) 1000-1006
27. Triantafilou M., Manukyan M., Mackie A., Morath S., Hartung T., Heine H., and Triantafilou K. Lipoteichoic acid and toll-like receptor 2 internalization and targeting to the Golgi are lipid raft-dependent. J. Biol. Chem. 279 (2004) 40882-40889
28. Vogel A.I., and Bassett J. Textbook of Quantitative Inorganic Analysis (1978), Longmans, London
29. von Aulock S., Morath S., Hareng L., Knapp S., van Kessel K.P., van Strijp J.A., and Hartung T. Lipoteichoic acid from Staphylococcus aureus is a potent stimulus for neutrophil recruitment. Immunobiology 208 (2003) 413-422